Why Vir Biotechnology's Stock Is trading Higher Today

Loading...
Loading...

Vir Biotechnology VIR shares are trading higher on Monday, after the company announced plans to work on coronavirus solutions with GlaxoSmithKline and a $250 million investment from the company.

Vir Biotechnology is a clinical-stage immunology company, developing therapeutic products to treat and prevent serious infectious diseases. The company has grant agreements with Bill & Melinda Gates Foundation.

Vir Biotechnology shares traded up 16.48% to $33.78 at time of publication on Monday. The stock has a 52-week high of $75 and a 52-week low of $11.65.

Posted In: BiotechNewsContractsMoversTrading IdeasGeneralwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...